Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 2519,"Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806.",blood sodium amount,,RS:0003328,SS/NEisSlc,male,91 days,12,,CMO:0000500,serum sodium level,,,,139.7,mmol/l,1.96,6.7896,MMO:0000142,automated serum sodium test,,0.0,,,,,controlled sodium content diet (8 %) (for 42 days) then 0.9% sodium chloride solution (0.3 ml) (for 42 days),100651,controlled sodium content diet (8 %) (for 42 days),0.9% sodium chloride solution (0.3 ml) (for 42 days) 2519,"Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806.",blood sodium amount,,RS:0003328,SS/NEisSlc,male,91 days,6,,CMO:0000500,serum sodium level,,,,139,mmol/l,3.09,7.5689,MMO:0000142,automated serum sodium test,,0.0,,,,,controlled sodium content diet (0.3 %) (for 91 days),100652,controlled sodium content diet (0.3 %) (for 91 days), 2519,"Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806.",blood sodium amount,,RS:0003328,SS/NEisSlc,male,91 days,6,,CMO:0000500,serum sodium level,,,,140.3,mmol/l,0.67,1.6412,MMO:0000142,automated serum sodium test,,0.0,,,,,controlled sodium content diet (8 %) (for 42 days) then cilazapril (10 mg/kg/d) (for 42 days),100655,controlled sodium content diet (8 %) (for 42 days),cilazapril (10 mg/kg/d) (for 42 days) 2519,"Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806.",blood sodium amount,,RS:0003328,SS/NEisSlc,male,91 days,6,,CMO:0000500,serum sodium level,,,,138.8,mmol/l,2.44,5.9768,MMO:0000142,automated serum sodium test,,0.0,,,,,controlled sodium content diet (8 %) (for 42 days) then candesartan (1 mg/kg/d) (for 42 days),100656,controlled sodium content diet (8 %) (for 42 days),candesartan (1 mg/kg/d) (for 42 days)